U-Blot® Research Grade Anti-SARS-CoV-2 RBD antibody (P2B-2F6)Cat. No. WA2392$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-SARS-CoV-2 RBD antibody (P2B-2F6)Cat. No. WA2392
U-Blot® Research Grade Anti-SARS-CoV-2 RBD antibody (H4)Cat. No. WA2391
U-Blot® Research Grade Anti-SARS-CoV-2 RBD Antibody (H014)Cat. No. WA2390
U-Blot® Research Grade Anti-SARS-CoV-2 RBD antibody (EY6A)Cat. No. WA2389
U-Blot® Research Grade Anti-SARS-CoV-2 RBD Antibody (CV30)Cat. No. WA2388
U-Blot® Research Grade Anti-SARS-CoV-2 RBD Antibody (CV2-75)Cat. No. WA2387
U-Blot® Research Grade Anti-SARS-CoV-2 RBD antibody (CR3022)Cat. No. WA2386
U-Blot® Research Grade Anti-SARS-CoV-2 RBD Antibody (COVA1-16)Cat. No. WA2385
U-Blot® Research Grade Anti-SARS-CoV-2 RBD Antibody (BG10-19)Cat. No. WA2384
U-Blot® Research Grade Anti-SARS-CoV-2 RBD Antibody (BD55-5840)Cat. No. WA2383
U-Blot® Research Grade Anti-SARS-CoV-2 RBD Antibody (BD55-5514)Cat. No. WA2382
U-Blot® Research Grade Anti-SARS-CoV-2 RBD antibody (B38)Cat. No. WA2381